Zhi-liang Wu

Statistics

Publications

Citations

151

H-Index

Active since

2001

Affiliations

Avalon Pharma (United States)(Current)

Zhi-liang Wu is an author at Avalon Pharma (United States) specializing in apoptosis in neurodegeneration, amyloid-beta-induced neurotoxicity, and apoptosis regulation.

Publications per year

2001–2001

Publications

CEP‐1347/KT‐7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ‐induced cortical neuron apoptosis

Donna Bozyczko‐Coyne, Teresa M. O’Kane, Zhi-liang Wu et al. · Journal of Neurochemistry · 2001 · 151 citations

Life Sciences, Neurobiology, Neuroscience +17

1–1 of 1